−£25.61m
vs Dec 2024Active12747523Private limited companyCambridge
TRANSITION BIO LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Transition Bio Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Transition Bio Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
TRANSITION BIO LIMITED is an active private limited company (company number 12747523) incorporated on 16 July 2020, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£25.61m and cash of £533k, with 23 employees on average. Net assets fell 38% on the prior period (−£18.51m).
Peer position · net assets
By net assets it sits in the bottom quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Ownership and control
No active person with significant control is registered.
- David Weitz
- owns 25–50% of shares
- holds 25–50% of voting rights
- Professor Tuomas Pertti Jonathan Knowles
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 16 July 20206 yrs ago
- Next accounts due
- 30 September 2027in 338 days
- Confirmation statement due
- 30 July 2027in 276 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£533k
+1861%vs Dec 2024Not reported
23
−8%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£25.61m | £533k | — | £30.46m | — | — | 23 |
| 31 December 2024 | −£18.51m | £27k | — | £23.18m | — | — | 25 |
Current ratio0.08Current assets ÷ creditors within one year
Cash per employee£23kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-25,612,218 at 31 December 2025
- Net assets down 25% or more on the prior period-38.4% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.08
- Cash at bank of £50,000 or moreCash £532,533
- Incorporated five or more years agoIncorporated 16 July 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 338 days
- Confirmation statement duein 276 days
- Accounts period endNet liabilities £25.61m · small accounts
- Accounts period endNet liabilities £18.51m · small accounts
- Incorporated
08
Similar companies in Cambridge
- ZYGOSITY LIMITEDCambridge · inc. Jul 2020
- SDS THERAPEUTICS LIMITEDCambridge · inc. Jul 2020
- MOSAIC THERAPEUTICS LIMITEDBabraham · inc. Jul 2020
- CELLRX LIMITEDCambridge · inc. Jun 2020
- RH PHARMA CONSULTING LTDEly · inc. Jun 2020
- KLURA LTDHaverhill · inc. Jun 2020
All companies incorporated on 16 July 2020 · in Jul 2020.
09
Reminders for TRANSITION BIO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.